Bloomage Biotechnology Corp Ltd
SSE:688363
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
44.97
80.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bloomage Biotechnology Corp Ltd
Bloomage Biotechnology Corp Ltd
Net Issuance of Debt
Bloomage Biotechnology Corp Ltd
Net Issuance of Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bloomage Biotechnology Corp Ltd
SSE:688363
|
Net Issuance of Debt
-¥14.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Net Issuance of Debt
¥2.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Net Issuance of Debt
-¥164.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Net Issuance of Debt
¥38m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Net Issuance of Debt
¥358.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bloomage Biotechnology Corp Ltd
Glance View
Nestled in the bustling corridors of the biotechnology industry, Bloomage Biotechnology Corp Ltd. has carved a niche as a leading player specializing in the production and innovation of biopolymers, with a particular emphasis on hyaluronic acid. Since its inception, the company has embraced a scientific approach combined with a robust business strategy, propelling it to the forefront of biotechnological advancements. Its operations are underpinned by a relentless pursuit of research and development, utilizing cutting-edge fermentation technology to manufacture high-quality hyaluronic acid that serves various industries such as cosmetics, food, and pharmaceuticals. Bloomage’s revenue model is intricately linked to the diverse applications of hyaluronic acid. By supplying raw materials to cosmetic giants, the company significantly taps into the lucrative beauty industry, as this compound is highly valued for its skin hydration properties. Additionally, Bloomage is involved in the healthcare segment, where it provides key ingredients for medical products that enhance joint health and accelerate wound healing. Through strategic partnerships and a focus on high-margin products, Bloomage not only diversifies its revenue streams but also sustains its position in competitive markets. This deliberate orchestration of science and commerce ensures the company remains at the vanguard of both innovation and profitability.
See Also
What is Bloomage Biotechnology Corp Ltd's Net Issuance of Debt?
Net Issuance of Debt
-14.2m
CNY
Based on the financial report for Sep 30, 2024, Bloomage Biotechnology Corp Ltd's Net Issuance of Debt amounts to -14.2m CNY.
What is Bloomage Biotechnology Corp Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
87%
Over the last year, the Net Issuance of Debt growth was 87%.
You don't have any saved screeners yet
